论文部分内容阅读
本文报告输鲜血治疗重症格林一巴利综合征85例并以81例,非输血病人作对照,病死率输血组为10.59%、对照组为27.16%,两组比较,差异有高度显著性(p<0.01)。存活者平均进展天数及开始恢复天数输血组为8.3及15.3天,对照组为11.7及18.0天,经统汁学处理差异有显著性(p<0.05)。提示输鲜血治疗能降低格林一巴利综合征病死率、缩短进展天数并能提前进入恢复期。
In this paper, 85 cases of severe Guillain-Barre syndrome were treated with blood transfusions and compared with 81 non-blood transfusion patients. The mortality rate was 10.59% in the blood transfusion group and 27.16% in the control group. The difference was significant <0.01). The average number of days of survival and the number of days to start recovering were 8.3 and 15.3 days in the transfusion group and 11.7 and 18.0 days in the control group, respectively. The differences were statistically significant (p <0.05). Suggesting that blood transfusions can reduce the mortality of Guillain-Barre syndrome, shorten the progress of the number of days and can advance to the recovery period.